European Archives - Page 1031 of 1157 - European Medical Journal

European Commission Approves TREVICTA®(Paliperidone Palmitate a 3-Monthly Injection), for Maintenance Treatment of Schizophrenia

BEERSE, BELGIUM, 31st May 2016 – Janssen-Cilag International NV announced today that the European Commission (EC) has approved the use of TREVICTA®…

Children’s Digestive Health Across Europe in Crisis

Brussels, 31 May, 2016: A report investigating the current state of digestive health in children has revealed alarming trends in disease incidence and…

EMJ

Promising Platelet Production Process Pioneered

MASS production of platelets is now one step closer, thanks to a team of researchers who have discovered a new method of creating platelet-producing…

EMJ

Exercise Proves Key to Preventing Cancer

AN INTERNATIONAL team of researchers have compiled data from 12 different studies demonstrating the important role exercise can play in helping to…

Introducing EMJ Hepatology 4.1

United Kingdom, May 31, 2016: Welcome to the latest edition of EMJ Hepatology, which provides a collection of articles on the latest hepatology research…

Review of the 51st International Liver Congress™ 2016

The historic architecture of Barcelona, Spain, was the backdrop to this year’s annual ILC congress, marking its 51st birthday. The city of Barcelona…

Welcome to the Real World: Hepatitis C Virus Clinical Trials to Patient Realities

The symposium addressed the efficacy and safety of compounds currently available for treatment of hepatitis C virus (HCV) and chronic kidney disease…

EMJ Hepatology 4.1 2016

Welcome to the latest edition of EMJ Hepatology, which provides a collection of articles on the latest hepatology research and news from…

Editor’s Pick: Clinical, Histological, and Molecular Classification of Hepatocellular Carcinoma: How Do They Get Along?

Hepatocellular carcinoma (HCC) will soon become a prominent part of the medical and economic burden on many Western countries’ healthcare systems.

The International Liver Congress (ILC) 2016: Rifaximin Use in Cirrhosis-Related Hepatological Disorders and New Perspectives

Rifaximin (RFX)-α is a broad-spectrum antibiotic that targets commensal gut bacteria and reduces the excess ammonia produced by the gut bacteria of…